Blog

ASLS Business Development Manager Dr. Lehanna Sanders shares her insights on the 3D bioprinting industry in this one-on-one discussion with

ASLS CEO Michael Golway featured in an interview with Dr. Craig Maxwell discussing the BioAssemblyBot platform and the path to printed organ

Scientists led by Dr. Rohan Shirwaiker at North Carolina State University have developed a way of arranging cells in 3D bioprinted gels

A team of researchers led by Dr. Vahid Serpooshan, an assistant professor of Biomedical Engineering and Pediatrics at Georgia Institute of T

MANCHESTER—Long waiting lists are a drag, but when they’re for an organ transplant, they can also be lethal. Over 120,000 Americans are...

3D.FAB, a French additive manufacturing platform, is developing a “living bandage” using 3D bioprinting and direct additive manufacturing.

“Generalized Biomanufacturing Platform for Dynamic Vascularized Tissues,” proposes the development of a manufacturing workflow solution

Dimension Inx, a company that develops biomaterials for 3D printing, has signed a distribution agreement with Advanced Solutions.

Join CEO, inventor and engineer, Michael Golway, as he offers insight into the agile manufacturing and biofabrication processes

While researchers see 3D printed organs in a clinical setting to be something like twenty years out most regular consumers see it a...

The Center for Engineering Complex Tissues (CECT) acquired a new BioAssemblyBot (BAB) 3D printer

Paul Goodwin, science director, GE Healthcare Life Sciences, discusses how 3D bioprinting could advance precision health in the future.

Our Chief Scientist Dr. James (Jay) Hoying featured on a panel with Derek Morris from United Therapeutics to discuss how we can dig deeper

The Kentucky-based company specializes in supporting 3D bioprinting teams, development labs, and research facilities.

BioAssemblyBot power user Dr. Christophe Marquette discusses insights regarding his work building vascularized skin tissue

Advanced Solutions Life Sciences (ASLS) is a leader in tissue fabrication and 3D bioprinting has the goal of 3d printing human organs.

We need companies that are willing to take a risk and people who are willing to be the example of what it takes to build a new industry....

A company that has the goal of mass producing human organs and tissue opened its doors Wednesday in Manchester. See More Here

ASLS Chief Scientist Dr. James (Jay) Hoying presents at University of Virginia Seminar Series: “ Microvascular Plasticity and Remodeling”

MANCHESTER – Michael Golway is so bullish on Dean Kamen and someday manufacturing human organs that he is moving a dozen staffers to...